Correction to “Synthesis and Activity Study of Gefitinib Derivatives Inducing Mitochondrial Apoptosis in HeLa Cells”

IF 3.3 4区医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

Chemical Biology & Drug Design Pub Date : 2025-07-23 DOI:10.1111/cbdd.70160

引用次数: 0

Abstract

Li, Y., Hou, X., Liu, S., Chen, Z., Wu, Q., He, B., Guo, J., Wang, L., Liu, C., Fei Mao, L. 2024. “Synthesis and Activity Study of Gefitinib Derivatives Inducing Mitochondrial Apoptosis in HeLa Cells.” Chemical Biology and Drug Design 104, no. 6: e70035.

The first affiliation was mistakenly listed as Zhoukou Center Hospital; however, the correct name should be Zhoukou Central Hospital.

The authors apologize for this error.

查看原文本刊更多论文

更正“吉非替尼衍生物诱导HeLa细胞线粒体凋亡的合成及活性研究”

X, Y。,侯,刘,年代,陈,Z,吴,问,他,B。,郭,J。,Wang L,刘,C。毛范,L . 2024。吉非替尼衍生物诱导HeLa细胞线粒体凋亡的合成及活性研究化学生物学与药物设计，第104期。6: e70035。第一家附属医院被错误地列为周口中心医院；但是，正确的名字应该是周口市中心医院。作者为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chemical Biology & Drug Design 医学-生化与分子生物学

CiteScore

5.10

自引率

3.30%

发文量

164

审稿时长

4.4 months

期刊介绍： Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design.